Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.09
+0.09 (1.29%)
At close: May 22, 2026, 4:00 PM EDT
7.28
+0.19 (2.68%)
After-hours: May 22, 2026, 6:40 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $437.82 million as of May 22, 2026. Its market cap has increased by 324.96% in one year.
Market Cap
437.82M
Enterprise Value
333.32M
1-Year Change
324.96%
Ranking
Category
Stock Price
$7.09
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $437.82M, an increase of 23.40%. That is a compound annual growth rate of 7.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 437.82M | 127.41% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 453.62M |
| Autolus Therapeutics | 452.44M |
| 4D Molecular Therapeutics | 449.58M |
| Neurogene | 437.87M |
| Fulcrum Therapeutics | 437.78M |
| ADC Therapeutics | 431.18M |
| Prelude Therapeutics | 429.47M |
| Ovid Therapeutics | 427.40M |